Analyst Price Target is $35.44
▼ -15.35% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Owens & Minor in the last 3 months. The average price target is $35.44, with a high forecast of $55.00 and a low forecast of $12.00. The average price target represents a -15.35% upside from the last price of $41.87.
Current Consensus is
The current consensus among 9 contributing investment analysts is to hold stock in Owens & Minor. This rating has held steady since November 2020, when it changed from a Buy consensus rating.
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. The company provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.